Ideally, cancer screening is taken annually as a part of regular health-check. A regular test allows a person to be completely aware of the health status.
PanTum Detect can detect tumors with a sensitivity of 97.5% and can rule out healthy individuals with a 99.53% specificity
97.5 % sensitivity
Out of 100 tumor patients, 97 are correctly identified as such by the blood test, indicating the extremely high accuracy of the test
99.53 % specificity
The chances of the test result indicating a false positive are negligible at 0.47 % or 1 in 200 only, indicating a higher reliability of the test
Yes, 99.5%, although, cancer can strike unexpectedly.
Yearly screening is beneficial for early detetction of Cancer, as it provides the opportunity of diagnosing a tumor early hence, allowing successful therapy.
In comparison to other preventive interventions and to commonly accepted cost-effectiveness benchmarks, cancer screening is highly cost-effective. Introduction of screening to populations previously unexposed to screening reduces cancer rates by 60% to 90% within 3 years of implementation.